Knockdown and overexpression experiments in hepatocytes and breast cancer cells demonstrated that cyclin D1 represses fatty acid oxidation by inhibiting peroxisome proliferator-activated receptor alpha (PPARα) activity, a nuclear receptor that induces fatty acid oxidation. Here, CCND1 is linked to breast carcinoma.